Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1992 Dec;66(6):1094–1098. doi: 10.1038/bjc.1992.416

Detection of RET oncogene activation in human papillary thyroid carcinomas by in situ hybridisation.

N Fabien 1, C Paulin 1, M Santoro 1, N Berger 1, M Grieco 1, D Galvain 1, Y Barbier 1, P M Dubois 1, A Fusco 1
PMCID: PMC1978047  PMID: 1457350

Abstract

We have recently reported the activation of a new oncogene in human papillary thyroid carcinomas. This oncogene, named PTC, is a novel rearranged version of the ret proto-oncogene. In fact PTC is the product of the fusion of the tyrosine kinase domain of the ret proto-oncogene with the 5'-terminal region of another gene that we have named H4. The ret proto-oncogene shows a pattern of expression restricted to neuroendocrine tissue. Its fusion with H4 allows the expression of the activated form in thyroid papillary carcinomas. Therefore the detection of ret transcripts is a tool to investigate ret activation in thyroid neoplasms. Here we show the detection by in situ hybridisation, of activated ret transcripts in human thyroid papillary neoplasms that were positive for PTC activation by Southern blot analysis. We did not find any ret transcripts in papillary carcinomas negative for PTC activation, nor in normal thyroid and in non-papillary thyroid neoplasias.

Full text

PDF
1094

Images in this article

1096Figure 1
on p.1096
1097Figure 2
on p.1097

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bongarzone I., Pierotti M. A., Monzini N., Mondellini P., Manenti G., Donghi R., Pilotti S., Grieco M., Santoro M., Fusco A. High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene. 1989 Dec;4(12):1457–1462. [PubMed] [Google Scholar]
  2. Fusco A., Grieco M., Santoro M., Berlingieri M. T., Pilotti S., Pierotti M. A., Della Porta G., Vecchio G. A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases. Nature. 1987 Jul 9;328(6126):170–172. doi: 10.1038/328170a0. [DOI] [PubMed] [Google Scholar]
  3. Grieco M., Santoro M., Berlingieri M. T., Melillo R. M., Donghi R., Bongarzone I., Pierotti M. A., Della Porta G., Fusco A., Vecchio G. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell. 1990 Feb 23;60(4):557–563. doi: 10.1016/0092-8674(90)90659-3. [DOI] [PubMed] [Google Scholar]
  4. Ikeda I., Ishizaka Y., Tahira T., Suzuki T., Onda M., Sugimura T., Nagao M. Specific expression of the ret proto-oncogene in human neuroblastoma cell lines. Oncogene. 1990 Sep;5(9):1291–1296. [PubMed] [Google Scholar]
  5. Ishizaka Y., Kobayashi S., Ushijima T., Hirohashi S., Sugimura T., Nagao M. Detection of retTPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method. Oncogene. 1991 Sep;6(9):1667–1672. [PubMed] [Google Scholar]
  6. Jenkins R. B., Hay I. D., Herath J. F., Schultz C. G., Spurbeck J. L., Grant C. S., Goellner J. R., Dewald G. W. Frequent occurrence of cytogenetic abnormalities in sporadic nonmedullary thyroid carcinoma. Cancer. 1990 Sep 15;66(6):1213–1220. doi: 10.1002/1097-0142(19900915)66:6<1213::aid-cncr2820660622>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  7. Lewis M. E., Sherman T. G., Burke S., Akil H., Davis L. G., Arentzen R., Watson S. J. Detection of proopiomelanocortin mRNA by in situ hybridization with an oligonucleotide probe. Proc Natl Acad Sci U S A. 1986 Aug;83(15):5419–5423. doi: 10.1073/pnas.83.15.5419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Pierotti M. A., Santoro M., Jenkins R. B., Sozzi G., Bongarzone I., Grieco M., Monzini N., Miozzo M., Herrmann M. A., Fusco A. Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC. Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1616–1620. doi: 10.1073/pnas.89.5.1616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Santoro M., Carlomagno F., Hay I. D., Herrmann M. A., Grieco M., Melillo R., Pierotti M. A., Bongarzone I., Della Porta G., Berger N. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J Clin Invest. 1992 May;89(5):1517–1522. doi: 10.1172/JCI115743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Santoro M., Rosati R., Grieco M., Berlingieri M. T., D'Amato G. L., de Franciscis V., Fusco A. The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene. 1990 Oct;5(10):1595–1598. [PubMed] [Google Scholar]
  11. Szentirmay Z., Ishizaka Y., Ohgaki H., Tahira T., Nagao M., Esumi H. Demonstration by in situ hybridization of ret proto-oncogene mRNA in developing placenta during mid-term of rat gestation. Oncogene. 1990 May;5(5):701–705. [PubMed] [Google Scholar]
  12. Takahashi M., Buma Y., Iwamoto T., Inaguma Y., Ikeda H., Hiai H. Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene. 1988 Nov;3(5):571–578. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES